Frost edit · Free shipping over $70 · Cool essentials

Login Register

glp 1 monoclonal antibody Frontiers Invitrogen™ GLP-1 Monoclonal Antibody (4)

glp 1 monoclonal antibody

glp 1 monoclonal antibody Frontiers Invitrogen™ GLP-1 Monoclonal Antibody (4)

SKU: 94302349707

4.9

USD21.63 USD67.63

Pay in 4 interest-free payments of $5.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 28 - Sep 2

Description

AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats

glp 1 monoclonal antibody Frontiers Invitrogen GLP-1 Monoclonal Antibody (4)

Why choose 1mg over 0.1mg

glp 1 monoclonal antibody Frontiers Invitrogen GLP-1 Monoclonal Antibody (4)

Peptides do not work overnight

glp 1 monoclonal antibody Frontiers Invitrogen GLP-1 Monoclonal Antibody (4)

Every treatment is reviewed by a licensed provider and tailored to your goals

glp 1 monoclonal antibody Frontiers Invitrogen GLP-1 Monoclonal Antibody (4)

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied

US$ 22.47

4.0 (16 reviews)

Glucagon-like peptide-1 receptor

Glucagon-like peptide-1 receptor

US$ 25.16

4.1 (6 reviews)

Identification of small-molecule GLP-1R agonists in a CHO-GLP-1R

Identification of small-molecule GLP-1R agonists in a CHO-GLP-1R

US$ 22.03

4.4 (15 reviews)

A potent novel small molecule GLP-1R agonist identified by rational design and CADD

A potent novel small molecule GLP-1R agonist identified by rational design and CADD

US$ 26.93

4.8 (5 reviews)

Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies

Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies

US$ 29.84

5.0 (12 reviews)

Discovery of Small-Molecule GLP-1 Receptor Agonists with Improved Oral Pharmacokinetics Based on Orforglipron

Discovery of Small-Molecule GLP-1 Receptor Agonists with Improved Oral Pharmacokinetics Based on Orforglipron

US$ 25.26

4.7 (13 reviews)

Ascletis Enters Small Molecule Oral GLP-1 RA Category with Positive Phase 1a Findings in Obesity

Ascletis Enters Small Molecule Oral GLP-1 RA Category with Positive Phase 1a Findings in Obesity

US$ 28.11

4.8 (6 reviews)

Figure 2 from Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor

Figure 2 from Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor

US$ 20.32

4.8 (17 reviews)

glp 1 peptid Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Glucagon-like peptide 1 in health –

glp 1 peptid Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Glucagon-like peptide 1 in health –

US$ 21.95

4.6 (18 reviews)

Structural and functional diversity among agonist-bound states of the GLP-1 receptor

Structural and functional diversity among agonist-bound states of the GLP-1 receptor

US$ 21.46

4.8 (26 reviews)

The chemical structures of two pyrimidine-based GLP-1 receptor

The chemical structures of two pyrimidine-based GLP-1 receptor

US$ 28.40

4.0 (23 reviews)

Small Molecule GLP-1 Agonists vs Peptide Analogs: What Changes at the Receptor Level?

Small Molecule GLP-1 Agonists vs Peptide Analogs: What Changes at the Receptor Level?

US$ 22.34

4.9 (5 reviews)

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1: Cell Metabolism

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1: Cell Metabolism

US$ 28.10

4.9 (12 reviews)

In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes

In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes

US$ 25.73

4.0 (11 reviews)

Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program

Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program

US$ 25.52

4.5 (16 reviews)

Noom offers cut-price compounded GLP-1 drug for obesity

Noom offers cut-price compounded GLP-1 drug for obesity

US$ 25.20

4.1 (7 reviews)

Noom GLP-1 Review 2026: Great App but Hidden Costs

Noom GLP-1 Review 2026: Great App but Hidden Costs

US$ 28.11

4.7 (18 reviews)

Noom Introduces Industry-First $129 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss

Noom Introduces Industry-First $129 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss

US$ 26.21

4.3 (28 reviews)

Noom expands its GLP-1 range with 'microdose' package

Noom expands its GLP-1 range with 'microdose' package

US$ 24.36

5.0 (25 reviews)

Microdosing GLP-1 for Weight Loss

Microdosing GLP-1 for Weight Loss

US$ 27.08

4.0 (17 reviews)